行情

XBIT

XBIT

XBiotech
NASDAQ

实时行情|Nasdaq Last Sale

11.49
+0.55
+5.03%
盘前: 13.40 +1.91 +16.62% 05:33 04/06 EDT
开盘
10.89
昨收
10.94
最高
11.58
最低
10.71
成交量
27.92万
成交额
--
52周最高
26.40
52周最低
6.76
市值
3.32亿
市盈率(TTM)
1.244
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测XBIT价格均价为28.00,最高价位28.00,最低价为28.00。

EPS

XBIT 新闻

更多
  • 为美元续命,美联储干了这件大事!
  • 新浪财经-自媒体综合 · 1小时前
  • 债务危机幽灵再现,激进放水后美联储或只剩一个策略
  • 新浪财经综合 · 1小时前
  • 德国今年经济或因疫情萎缩3-6%
  • 新浪财经 · 2小时前
  • 土豪国也撑不住:迪拜最大地产公司全员减薪
  • 新浪财经 · 2小时前

所属板块

生物技术和医学研究
-0.50%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

XBIT 简况

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).
展开

微牛提供XBiotech Inc(NASDAQ-XBIT)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的XBIT股票新闻,以帮助您做出投资决策。